LifeStance Health rallies after sponsors' $590 mln share offload

By Reuters News

** Outpatient mental healthcare provider LifeStance Health's LFST.O shares reverse early losses and last up 6.6% at $14.69 on Mon after secondary offering priced

** LFST stock on course for biggest one-day pct gain in three months

** Scottsdale, Arizona-based LFST early Mon announced 45 mln share offering by certain holders at $13.12 for deal size of $590.4 mln

** Offering priced at 4.7% discount to stock's last sale on Fri

** Private equity firms TPG Capital TPG.O and Summit Partners selling ~37.2 mln shares and ~7.8 mln shares, respectively, per the prospectus

** In addition, LFST concurrently repurchasing 2 mln of offering shares from bookrunners Barclays and JP Morgan

** TPG and Summit sold LFST shares in a Sept secondary offering priced at $12.35

** LFST had ~380.2 mln shares outstanding as of Oct 28

** Co early on Thurs posted Q3 rev beat, driven primarily by higher visit volumes from net clinician growth, and hiked its 2026 outlook

** With move on the session, stock up 108% YTD

** 9 of 11 analysts rate the stock "strong buy" or "buy", 2 "hold"; median PT of $16.50 up from $13 three months ago, per LSEG

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.